140
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Variables Associated with 30-Day Mortality in Very Elderly COVID-19 Patients

ORCID Icon, , ORCID Icon, , ORCID Icon & ORCID Icon
Pages 1155-1162 | Received 14 Apr 2023, Accepted 11 Jul 2023, Published online: 25 Jul 2023

References

  • Bonanad C, García-Blas S, Tarazona-Santabalbina F, et al. The effect of age on mortality in patients with COVID-19: a meta-analysis with 611,583 subjects. J Am Med Dir Assoc. 2020;21(7):915–918. doi:10.1016/j.jamda.2020.05.045
  • Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020;180(7):934–943. doi:10.1001/jamainternmed.2020.0994
  • National Institutes of Health. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. Available from: https://www.covid19treatmentguidelines.nih.gov/. Accessed July 13, 2023.
  • Chen Y, Klein SL, Garibaldi BT, et al. Aging in COVID-19: vulnerability, immunity and intervention. Ageing Res Rev. 2021;65:101205. doi:10.1016/j.arr.2020.101205
  • Alharthy A, Aletreby W, Faqihi F, et al. Clinical characteristics and predictors of 28-day mortality in 352 critically ill patients with COVID-19: a retrospective study. J Epidemiol Glob Health. 2020;11(1):98–104. doi:10.2991/jegh.k.200928.001
  • 中华人民共和国国家卫生健康委员会办公厅, 中华人民共和国国家中医药管理局综合司 [General Office of National Health Commission of the People's Republic of China]. 新型冠状病毒感染诊疗方案(试行第十版) [Diagnosis and treatment of the coronavirus disease 2019 (the 10th version)]. 中国医药. 2023;18(2):161–166.
  • Coronavirus disease 2019 (COVID-19) treatment guidelines. Available from: https://www.covid19treatmentguidelines.nih.gov/. Accessed July 13, 2023.
  • Ayoub HH, Chemaitelly H, Mumtaz GR, et al. Characterizing key attributes of COVID-19 transmission dynamics in China’s original outbreak: model-based estimations. Glob Epidemiol. 2020;2:100042. doi:10.1016/j.gloepi.2020.100042
  • Shaw AC, Joshi S, Greenwood H, Panda A, Lord JM. Aging of the innate immune system. Curr Opin Immunol. 2010;22:507–513. doi:10.1016/j.coi.2010.05.003
  • Da Costa JC, Manso MC, Gregório S, Leite M, Pinto JM. Barthel’s index: a better predictor for COVID-19 mortality than comorbidities. Tuberc Respir Dis. 2022;85(4):349–357. doi:10.4046/trd.2022.0006
  • Zhang XM, Jiao J, Cao J, et al. Frailty as a predictor of mortality among patients with COVID-19: a systematic review and meta-analysis. BMC Geriatr. 2021;21:186. doi:10.1186/s12877-021-02138-5
  • Pranata R, Henrina J, Lim MA, et al. Clinical frailty scale and mortality in COVID-19: a systematic review and dose-response meta-analysis. Arch Gerontol Geriatr. 2021;93:104324. doi:10.1016/j.archger.2020.104324
  • Paula HSC, Santiago SB, Araújo LA, et al. An overview on the current available treatment for COVID-19 and the impact of antibiotic administration during the pandemic. Braz J Med Biol Res. 2021;55:e11631. doi:10.1590/1414-431x2021e11631
  • Gallo Marin B, Aghagoli G, Lavine K, et al. Predictors of COVID-19 severity: a literature review. Rev Med Virol. 2021;31(1):1–10. PMID: 32845042; PMCID: PMC7855377. doi:10.1002/rmv.2146
  • Ma A, Cheng J, Yang J, Dong M, Liao X, Kang Y. Neutrophil-to-lymphocyte ratio as a predictive biomarker for moderate-severe ARDS in severe COVID-19 patients. Crit Care. 2020;24(1):288. doi:10.1186/s13054-020-03007-0
  • Rostami M, Mansouritorghabeh H. D-dimer level in COVID-19 infection: a systematic review. Expert Rev Hematol. 2020;13(11):1265–1275. doi:10.1080/17474086.2020.1831383
  • Zhan H, Chen H, Liu C, et al. Diagnostic value of D-dimer in COVID-19: a meta-analysis and meta-regression. Clin Appl Thromb Hemost. 2021;27:10760296211010976. doi:10.1177/10760296211010976
  • Zhang L, Yan X, Fan Q, et al. D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19. J Thromb Haemost. 2020;18(6):1324–1329. doi:10.1111/jth.14859
  • Docherty AB, Harrison EM, Green CA, et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO clinical characterisation protocol: prospective observational cohort study. BMJ. 2020;369:m1985. doi:10.1136/bmj.m1985
  • Izcovich A, Ragusa MA, Tortosa F, et al. Prognostic factors for severity and mortality in patients infected with COVID-19: a systematic review. PLoS One. 2020;15(11):e0241955. doi:10.1371/journal.pone.0241955
  • Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. doi:10.1016/S0140-6736(20)30566-3
  • Cheng Y, Luo R, Wang K, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020;97(5):829–838. doi:10.1016/j.kint.2020.03.005